Complete Patient Support Programs logo
  • Important Safety Information
    Full Prescribing Information
    RINVOQ® / RINVOQ® LQ
    Important Safety Information,
    including BOXED WARNING

    Full Prescribing Information
    HUMIRA®
    Important Safety Information,
    including BOXED WARNING

    Full Prescribing Information
    SKYRIZI®
    Important Safety Information
    Full Prescribing Information
  • <Variable Practice Name> Account Menu
    <Variable Practice Name>
    <Variable User Name>
    Settings Log Out
Complete Pro
Continue
RINVOQ upadacitinib and RINVOQ LQ logo
HUMIRA adalimumab logo
SKYRIZI risankizumab-rzaa logo

Click for RINVOQ/RINVOQ LQ Important Safety Information, including BOXED WARNING on Serious Infections, Mortality, Malignancies, Major Adverse Cardiovascular Events, and Thrombosis.

Click for HUMIRA Important Safety Information, including BOXED WARNING on Serious Infections and Malignancy.

Click for SKYRIZI Important Safety Information.

Full prescribing information for RINVOQ/RINVOQ LQ, HUMIRA, and SKYRIZI.

Privacy Notice | Cookie Settings | Your Privacy Choices

US-MULT-240825 | ©AbbVie 2025. Patent Pending. | Contact Us | Accessibility Statement

Contact Us

Technical Support

877-COMPLETE (877-266-7538) Option 3

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

AbbVie Access Support

877-COMPLETE (877-266-7538) Option 2

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

myAbbVie Assist Patient Assistance

Phone: 800-222-6885

Fax: 866-250-2803

Customer Solutions Specialist

Field Reimbursement Manager

Back

US-MULT-240985